Topic guide
Ketamine
How ketamine differs from classic psychedelics—and what to examine when assessing treatment, safety and clinic claims.
Start with context
Ketamine has established medical uses and a different mechanism, evidence base and regulatory position from psilocybin or LSD. Grouping them together can obscure important differences in risk and clinical delivery.
Questions this topic raises
- Which ketamine formulation and route is being discussed?
- Is the use licensed, off-label or experimental?
- What monitoring and follow-up are provided?
- Are benefits and risks described in balanced terms?
- Is the provider making claims stronger than the evidence?
Read the evidence guides
Ketamine and Classic Psychedelics Are Not the Same
Compare pharmacology, clinical use, evidence, legal status and risk.
Screening, Contraindications and Risk in Psychedelic Research
What clinical trials screen and monitor—and why selected study populations cannot be generalised.
How to Spot Misleading Psychedelic Clinic and Retreat Claims
Test treatment promises, credentials, regulation, testimonials and safety claims before money or trust changes hands.
What Does “Psychedelic-Assisted Therapy” Really Mean?
A guide to preparation, monitored sessions, psychological support and integration.
Keep the boundary clear
These guides are educational. They do not provide medical advice, personalised risk assessment, legal advice or instructions for using a controlled substance.
